SurgePays (SURG) Competitors $2.11 -0.08 (-3.84%) As of 02:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock SURG vs. SKIN, OM, BWAY, SMTI, SGHT, MGRM, CVRX, SI, KRMD, and CVShould you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include Beauty Health (SKIN), Outset Medical (OM), Brainsway (BWAY), Sanara MedTech (SMTI), Sight Sciences (SGHT), Monogram Orthopaedics (MGRM), CVRx (CVRX), Shoulder Innovations (SI), KORU Medical Systems (KRMD), and CapsoVision (CV). These companies are all part of the "medical equipment" industry. SurgePays vs. Its Competitors Beauty Health Outset Medical Brainsway Sanara MedTech Sight Sciences Monogram Orthopaedics CVRx Shoulder Innovations KORU Medical Systems CapsoVision Beauty Health (NASDAQ:SKIN) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment. Is SKIN or SURG more profitable? Beauty Health has a net margin of -6.13% compared to SurgePays' net margin of -133.85%. Beauty Health's return on equity of -32.82% beat SurgePays' return on equity.Company Net Margins Return on Equity Return on Assets Beauty Health-6.13% -32.82% -2.96% SurgePays -133.85%-250.67%-173.99% Do institutionals & insiders have more ownership in SKIN or SURG? 93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 6.9% of SurgePays shares are owned by institutional investors. 41.0% of Beauty Health shares are owned by company insiders. Comparatively, 30.5% of SurgePays shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend SKIN or SURG? Beauty Health currently has a consensus price target of $2.63, indicating a potential upside of 19.05%. SurgePays has a consensus price target of $9.00, indicating a potential upside of 326.54%. Given SurgePays' stronger consensus rating and higher possible upside, analysts plainly believe SurgePays is more favorable than Beauty Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beauty Health 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00SurgePays 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings & valuation, SKIN or SURG? Beauty Health has higher revenue and earnings than SurgePays. Beauty Health is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeauty Health$334.30M0.83-$29.10M-$0.28-7.88SurgePays$60.88M0.71-$45.73M-$2.49-0.85 Does the media prefer SKIN or SURG? In the previous week, Beauty Health had 10 more articles in the media than SurgePays. MarketBeat recorded 20 mentions for Beauty Health and 10 mentions for SurgePays. Beauty Health's average media sentiment score of 0.87 beat SurgePays' score of 0.17 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 13 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive SurgePays 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, SKIN or SURG? Beauty Health has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, SurgePays has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. SummaryBeauty Health beats SurgePays on 12 of the 16 factors compared between the two stocks. Get SurgePays News Delivered to You Automatically Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SURG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SURG vs. The Competition Export to ExcelMetricSurgePaysINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$43.17M$19.63B$29.72B$9.81BDividend YieldN/A3.37%3.08%4.07%P/E Ratio-0.8574.2951.9325.56Price / Sales0.71197.121,332.53116.21Price / CashN/A84.0936.4959.48Price / Book2.7817.989.116.14Net Income-$45.73M$347.70M$803.97M$264.98M7 Day Performance-27.74%1.04%1.04%2.75%1 Month Performance-28.47%-0.31%0.74%3.15%1 Year Performance11.05%62.78%24,093.19%25.14% SurgePays Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SURGSurgePays3.4114 of 5 stars$2.11-3.8%$9.00+327.4%+10.1%$43.17M$60.88M-0.8540News CoverageEarnings ReportGap UpSKINBeauty Health1.8241 of 5 stars$2.21+16.9%$2.63+18.8%+68.2%$238.13M$334.30M-7.891,030Trending NewsHigh Trading VolumeOMOutset Medical1.7849 of 5 stars$12.43-2.9%$24.67+98.4%+3.2%$227.41M$113.69M-0.61520BWAYBrainsway3.9413 of 5 stars$12.10+2.9%$14.25+17.8%+68.2%$222.24M$41.02M60.50120News CoverageEarnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionHigh Trading VolumeSMTISanara MedTech2.1691 of 5 stars$26.86+8.3%$49.50+84.3%-7.1%$220.42M$86.67M-20.0460News CoverageEarnings ReportSGHTSight Sciences1.6789 of 5 stars$4.12-2.8%$4.27+3.6%-26.6%$219.19M$79.87M-4.29210MGRMMonogram Orthopaedics2.0752 of 5 stars$5.38-0.4%$5.40+0.4%+98.1%$192.71M$370K-11.9628Short Interest ↓CVRXCVRx2.8421 of 5 stars$7.51+3.7%$14.00+86.4%-9.2%$189.34M$51.29M-3.58160SIShoulder InnovationsN/A$12.08-2.7%N/AN/A$188.99MN/A-0.4061Positive NewsKRMDKORU Medical Systems1.9617 of 5 stars$4.04+2.0%$4.63+14.5%+78.4%$183.09M$33.65M-44.8980Positive NewsCVCapsoVisionN/A$4.11+4.6%$5.50+33.8%N/A$182.13MN/A0.0090News CoverageQuiet Period Expiration Related Companies and Tools Related Companies Beauty Health Competitors Outset Medical Competitors Brainsway Competitors Sanara MedTech Competitors Sight Sciences Competitors Monogram Orthopaedics Competitors CVRx Competitors Shoulder Innovations Competitors KORU Medical Systems Competitors CapsoVision Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SURG) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SurgePays, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SurgePays With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access